naturalX Health Ventures

naturalX Health Ventures primarily invests in Series A and Series B stages, targeting companies that show clear indications of product-market fit. The fund typically invests between €3 million and €10 million per company. Their investment strategy encompasses a wide range of sectors within consumer health, including proactive health, mental health, and the intersection of consumer and health technologies.

Specific areas of interest include prevention, longevity, sleep, nutrition, bio-hacking, genomics, wearables, digital therapeutics, at-home diagnostics, and remote care. The firm seeks to partner with founders who are committed to bridging traditional wellness and modern medicine, emphasizing science-backed natural approaches to health.

naturalX Health Ventures has invested in a diverse array of companies within the consumer health sector. The portfolio includes:

• Jutro Medical (Founded 2019, Warsaw, Poland): A digital healthcare provider offering accessible primary care through technology-driven clinics and a mobile platform.
• Function Health (Founded 2021, Austin, US): A consumer health platform providing comprehensive lab testing and personalized insights for proactive health management.
• Hilo (Founded 2018, Neuchâtel, CH): A consumer wearable that offers continuous, cuffless blood pressure monitoring for real-time cardiovascular insights.
• Kyan Health (Founded 2021, Zurich, CH): An AI-powered solution aimed at transforming workplace wellbeing into measurable business impact through predictive and preventative care.
• Flow Neuroscience (Founded 2011, Malmö, Sweden): Developer of a brain stimulation headset targeting both physical and behavioral aspects of major depressive disorder.
• Meela Health (Founded 2021, Gothenburg, Sweden): A platform that matches individuals with the appropriate therapist and therapy method.
• mybacs (Founded 2019, Zurich, CH): A research-driven direct-to-consumer company focused on the human microbiome.

This portfolio reflects naturalX Health Ventures' commitment to investing in innovative solutions that address various aspects of consumer health.

Marvin Amberg, Managing Director: Marvin has extensive experience in venture capital and consumer health, having previously worked with leading investment firms. He focuses on identifying promising startups and guiding them through the investment process.

Clementine Provost, Investor: Clementine specializes in consumer health investments and has a background in healthcare consulting. She brings valuable insights into market trends and startup dynamics.

Yang Chen, PhD, Investor: Yang holds a PhD in a relevant field and has a strong background in health technology. His expertise aids in evaluating the scientific validity of potential investments.

Sarah Bossong, Platform Manager: Sarah manages the firm's portfolio and supports startups in their growth journeys, ensuring they have access to necessary resources and strategic guidance.

To pitch to naturalX Health Ventures, founders should visit their website at naturalx.vc or send an email to info@naturalx.vc. It is recommended to include a comprehensive pitch deck that outlines the business model, market analysis, and team qualifications.

Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, but not mandatory.

As of March 2023, naturalX Health Ventures has been actively building its portfolio, focusing on investments that align with its commitment to consumer health. Recent investments include companies that provide innovative solutions in proactive health and technology-driven healthcare.

While there have been no recent blog posts or updates published, the firm continues to engage with its portfolio companies to support their growth and success in the market.